Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB
Clicks: 183
ID: 271471
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
183 views
19 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #18 of 48 articles by views in journal of antimicrobial chemotherapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractObjectives. Fluoroquinolones (FQs) are important in the treatment of MDR-TB and in the definition of XDR-TB. Our objective was to investigate how discre
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (23 words).
Try re-searching for a better abstract.
| Reference Key |
katarina2016journalsusceptibility
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Niward, Katarina;Ängeby, Kristian;Chryssanthou, Erja;Paues, Jakob;Bruchfeld, Judith;Jureen, Pontus;Giske, Christian G.;Kahlmeter, Gunnar;Schön, Thomas; |
| Journal | journal of antimicrobial chemotherapy |
| Year | 2016 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.